A retrospective chart review in patients with aggressive lymphoma (NHL) received axicabtagene ciloleucel at Mayo Clinic
Latest Information Update: 12 Oct 2022
At a glance
- Drugs Axicabtagene ciloleucel (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
Most Recent Events
- 12 Oct 2022 New trial record
- 01 Oct 2022 Results published in the Clinical Lymphoma, Myeloma & Leukemia